Market revenue in 2023 | USD 819.2 million |
Market revenue in 2030 | USD 1,127.9 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 49.79% in 2023. Horizon Databook has segmented the Canada interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
In February 2022, according to research released by the Heart and Stroke Foundation, in Canada, 750,000 people have been diagnosed with heart failure and 100,000 are identified with this fatal condition yearly. This presents a significant market opportunity for innovative stroke care, treatment, and prevention solutions.
This rise in stroke cases, equating to approximately one stroke every 5 minutes, underscores the urgent need for strong stroke care systems and better preventive measures across the country. In Canada, advancements in minimally invasive procedures, telemedicine, and remote monitoring solutions have been significant in the interventional cardiology market, particularly due to the COVID-19 pandemic.
Recently, in June 2023, Cook Medical announced the availability of its Advance Serenity hydrophilic Percutaneous Transluminal Angioplasty (PTA) balloon catheter product line across Canada, including the U.S., at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM). Surmodics manufactures the catheters that are disturbed across the country by Cook Medical.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Canada interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account